Hospital Procedure Volume Not Associated With 30-Day Stroke Rate for Transcarotid or Transaxillary/Subclavian Transcatheter Aortic Valve Replacement.

Ann Thorac Surg

Center for Cardiovascular Analytics, Research, and Data Sciences, Providence Heart Institute, Providence St Vincent Medical Center, 9427 SW Barnes Rd, Ste 593, Portland, OR 97225.

Published: January 2022

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2021.04.016DOI Listing

Publication Analysis

Top Keywords

hospital procedure
4
procedure volume
4
volume associated
4
associated 30-day
4
30-day stroke
4
stroke rate
4
rate transcarotid
4
transcarotid transaxillary/subclavian
4
transaxillary/subclavian transcatheter
4
transcatheter aortic
4

Similar Publications

Background: Delirium is a condition characterized by an acute and transient disturbance in attention, cognition, and consciousness. It is increasingly prevalent at the end of life in patients with cancer. While non-pharmacological nursing interventions are essential for delirium prevention, their effectiveness in terminally ill patients with cancer remains unclear.

View Article and Find Full Text PDF

Background: Cancer is a leading cause of global mortality, accounting for nearly 10 million deaths in 2020. This is projected to increase by more than 60% by 2040, particularly in low- and middle-income countries. Yet, palliative and psychosocial oncology care is very limited in these countries.

View Article and Find Full Text PDF

Objective: The effectiveness and optimal stimulation site of deep brain stimulation (DBS) for central poststroke pain (CPSP) remain elusive. The objective of this retrospective international multicenter study was to assess clinical as well as neuroimaging-based predictors of long-term outcomes after DBS for CPSP.

Methods: The authors analyzed patient-based clinical and neuroimaging data of previously published and unpublished cohorts from 6 international DBS centers.

View Article and Find Full Text PDF

Background: Acute kidney injury (AKI) is a common complication in hospitalized older patients, associated with increased morbidity, mortality, and health care costs. Major adverse kidney events within 30 days (MAKE30), a composite of death, new renal replacement therapy, or persistent renal dysfunction, has been recommended as a patient-centered endpoint for clinical trials involving AKI.

Objective: This study aimed to develop and validate a machine learning-based model to predict MAKE30 in hospitalized older patients with AKI.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!